CompoAtlas

SAFRALITE 30 MG

Food supplement declared in France, declaration No 2024-5-1186, decision dated 24 May 2024

SAFRALITE 30 MG is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
not provided
Food business operator placing the product on the market
LABORATOIRE DENEL
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
1 gélule par jour
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes, Sous antidépresseurs
Objectives stated by the manufacturer (these are not authorised claims)
Humeur

Declaration 142033, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Griffonia simplicifolia (DC.) Baill.GraineExtrait sec aqueux168 mg
Crocus sativus L.StigmatesExtrait sec hydroalcoolique30 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
Citrate de zincZinc25 mg15 mg

Additives

E464, E470b, E460

Other ingredients

amidon de riz

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Déconseillé en cas de prise d’antidépresseurs, trisomie 21 et sclérodermie.Déconseillé aux femmes enceintes et allaitantes.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line